Chembio Diagnostics Inc. | Mutual Funds
Mutual Funds that own Chembio Diagnostics Inc.
Vanguard Total Stock Market Index Fund
329,680
2.33%
0
0%
07/31/2018
Vanguard Extended Market Index Fund
157,238
1.11%
0
0%
07/31/2018
Royce Capital Fund - Micro Cap Portfolio
132,900
0.94%
46,600
0.67%
06/30/2018
Royce Micro Cap Fund
127,953
0.9%
37,400
0.64%
06/30/2018
Bridgeway Ultra Small Company Fund
80,100
0.56%
0
0.81%
12/31/2017
Fidelity Spartan Extended Market Index Fund
41,523
0.28%
0
0%
07/31/2018
iShares Micro Cap ETF
38,965
0.28%
0
0.04%
09/06/2018
Royce Micro Cap Trust
33,300
0.24%
0
0.08%
06/30/2018
Vanguard Institutional Total Stock Market Index Fund
20,971
0.15%
0
0%
07/31/2018
Vanguard Balanced Index Fund
9,639
0.07%
0
0%
07/31/2018
| Address |
3661 Horseblock Road
Medford New York 11763
United States
|
|
Employees
|
- |
| Website |
http://www.chembio.com |
| Updated |
07/08/2019 |
| Chembio Diagnostics, Inc. develops, manufactures, markets and licenses rapid point-of-care diagnostic tests that detect infectious diseases. It sells its products under its STAT PAK, SURE CHECK, DPP and SampleTainer trademarks. The company was founded on May 5, 2004 and is headquartered in Medford, NY. |
